 Respiratory mucus hypersecretion bronchorrhea case discussion possible mechanisms treatment mechanism mucus hypersecretion bronchorrhea treatment condition understood erythromycin mucus secretion human airways secretory epithelial cells vitro patient airway obstruction severe bronchorrhea bronchodilators high-dose prednisone Many attempts prednisone course disease IgG antibody vasoactive intestinal peptide amounts mucus respiratory epithelial cells hyperreactive airways methacholine challenge provocation test Erythromycin therapy effect erythromycin treatment dramatic clinical laboratory improvement short trial erythromycin patient low every-other-day doses prednisone significant reduction volume bronchorrhea major decrease epithelial mucins total expectorated mucus complete inhibition airway hyperresponsiveness methacholine significant reduction level IgG antibody vasoactive intestinal peptide response specific erythromycin antibiotics clinical biochemical physiologic effects erythromycin role treatment patients bronchorrhea steroid-sparing effect Additional studies numbers patients